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Abstract
Eleven papers on trauma published in Critical Care during 2008
addressed traumatic brain injury (TBI), burns, diagnostic concerns
and immunosuppression. In regard to TBI, preliminary results
indicate the utility of either magnetic resonance imaging (MRI) or
ultrasound in measuring optic nerve sheath diameter to identify
elevated intracranial pressure (ICP) as well as the potential benefit
of thiopental for refractory ICP. Another investigation demonstrated
that early extubation of TBI patients whose Glasgow Coma Scale
score was 8 or less did not result in additional incidence of noso-
comial pneumonia. Another study indicated that strict glucose
control resulted in worse outcomes during the first week after TBI,
but improved outcomes after the second week. Another paper
showed the prolonged neuroprotective advantages of proges-
terone administration in TBI patients. There was also guidance on
improved classifications of renal complications in burn patients.
Another study found that patients with inhalation injuries and
increased interleukin-6 (IL-6) and IL-10 and decreased IL-7 had
increased mortality rates. One literature review described the
disadvantages of prolonged immobilization or additional use of MRI
for ruling out cervical spine injuries in obtunded TBI patients
already cleared by computerized tomography scans. Other
investigators found that higher N-terminal pro B-type natriuretic
peptide (NT-proBNP) levels may be useful markers for post-
traumatic cardiac impairment. Finally, an experimental model
showed that both splenic apoptosis and lymphocytopenia may
occur shortly after severe hemorrhage, thus increasing the threat of
immunosuppression in those with severe blood loss.
Introduction
During 2008, Critical Care published a number of papers in
regard to injured patients. Several of these articles focused
on identification and treatment strategies for traumatic brain
injury (TBI) and increased intracranial pressure (ICP). Another
examined acute renal injury in burn patients, and one
described a novel method of assessing serum markers of
burn severity. Finally, there were several articles applicable to
the multiple-injury patients, including those articles that
examined the potential adverse effects of prolonged cervical
immobilization or the practice of adding magnetic resonance
imaging (MRI) to computerized tomography (CT) scans in
ruling out cervical spine injuries. Another article demonstrated
the utility of obtaining N-terminal pro B-type natriuretic
peptide (NT-proBNP) in identifying multiple organ dysfunction
syndrome and decreased cardiac index in multiple-injury
patients. The final paper was an experimental investigation
that demonstrated two of the potential mechanisms for post-
traumatic immunosuppression.
Traumatic brain injury
One of the challenges in treating patients with TBI is the
identification of increased ICP. Increased ICP is known to
affect outcomes [1] but often requires invasive catheters to
determine its presence and monitor its course. One non-
invasive modality that has been examined is the use of ultra-
sound to detect changes in the optic nerve sheath diameter
(ONSD). Many of the research studies evaluating the use of
ONSD in elevated ICP have used indirect methods to confirm
elevated ICP, including CT findings and transcranial Doppler
[2-6]. In their 2008 Critical Care article in regard to this
subject, Soldatos and colleagues [7] used an intra-
parenchymal catheter to directly measure ICP and found that
an ONSD of 5.7 mm was the optimal cutoff value for detect-
ing an ICP of greater than 20 (sensitivity and specificity of
74.1% and 100%, respectively) and that ultrasound measure-
ment of ONSD correlated well with invasive and noninvasive
measurements of ICP. These results are similar to those of
Geeraerts and colleagues [8] and Kimberley and colleagues
[9], suggesting that an ONSD of between 5 and 5.8 can
reliably detect elevated ICP, depending on what sensitivity
and specificity are desired. While ultrasound is a commonly
available and easily performed test, many patients with head
injury or other causes of increased ICP may also undergo an
MRI. Using MRI, Geeraerts and colleagues [10] performed a
study in which they measured ONSD to determine how well it
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correlates with ICP and found similar results; a diameter of
5.82 mm is the optimal diameter for predicting the presence
of elevated ICP.
Patients with TBI and an elevated ICP that is refractory to all
other medical and surgical treatment modalities may very well
benefit from high-dose barbiturate therapy, although this
practice remains controversial in some centers given its
associated high morbidity [11]. However, few data comparing
different barbiturate regimens exist. In another 2008 trauma
paper in Critical Care, Pérez-Bárcena and colleagues [12]
randomly assigned 44 patients with TBI and refractory
intracranial hypertension to receive high-dose thiopental or
high-dose pentobarbital drips. The authors showed better
ICP control with thiopental (odds ratio = 5.1, confidence
interval = 1.2 to 21.9; P = 0.027). Though encouraging, this
trial involved a small patient cohort with an unblinded study
design. In addition, there were more patients with brain
swelling on the initial CT scan in the pentobarbital group, so
these preliminary results must be interpreted with caution.
Current practice management guidelines dictate the need for
airway protection in patients with TBI and a Glasgow Coma
Scale (GCS) score of 8 or less for respiratory protection and
prevention of aspiration into the lungs [13]. It has been
suggested, however, that prolonged endotracheal intubation
leads to increased risk of pneumonia as well as longer
intensive care unit (ICU) and overall hospital stays [14]. The
2008 study by Manno and colleagues [15] in Critical Care
begins to address this issue. They randomly assigned 16
patients to an early extubation arm versus a delayed extu-
bation arm. Although the study was designed to assess study
feasibility and to determine the necessary sample size for a
higher powered study, it did show that none of the patients in
the early extubation arm developed nosocomial pneumonia
compared with 37% in the delayed extubation arm. Although
the study was underpowered for significant statistical
analysis, this very impressive trend was compelling and the
concept should be examined further [15].
Prevention of secondary injury is perhaps the most important
goal in the critical care of those with TBI. The recent critical
care literature has demonstrated significant debate concern-
ing the optimal range and method of glycemic control in many
critical illnesses [16-18]. It remains to be seen, however, how
strict the glycemic control needs to be in severe TBI. Several
recent studies have suggested that hypoglycemic episodes
lead to metabolic derangement with lactate production and
secondary brain injury [19-23]. A study from Zurich,
Switzerland, by Meier and colleagues [24] published in 2008
in Critical Care showed that there appears to be a temporal
relationship between glucose control and benefit. In their
investigation, they compared a strict glucose control regimen
maintaining a blood glucose of between 3.5 and 6.5 mmol/L
(63 and 117 mg/dL) with a regimen maintaining a blood
glucose of between 5 and 8 mmol/L (90 and 144 mg/dL).
The lower glucose range was associated with a trend toward
increased mortality during the first two weeks. The tight
control was also associated with markedly increased insulin
and norepinephrine requirements, increased frequencies of
hyperglycemic and hypoglycemic episodes, and significantly
elevated ICP during the first week after admission. In
contrast, during the second week, maintaining patients in the
lower glucose range resulted in lower ICP and reduced rates
of pneumonia, bacteremia, and urinary tract infections when
compared with the group in the higher glucose range. Based
on these results, future research efforts should take into
account these temporal factors. Lastly, with regard to TBI,
progesterone has been shown to have neuroprotective
benefits in several different animal models of injury [25-27].
More recently, it was shown to have improved mortality and,
in patients with moderate brain injury, better outcomes than
those receiving placebo for up to 30 days after injury in
humans with TBI [28]. In the first issue of Critical Care for
2008, Xiao and colleagues [29] report the results of a related
investigation, in which they followed outcomes for up to 6
months to determine whether the benefit was persistent. They
found that, at both 3 and 6 months, patients who received
progesterone had outcomes that were more favorable as
measured by the GCS and the modified functional
independence measure. More importantly, progesterone was
associated with decreased mortality at 6 months. Along with
existing experimental and preliminary clinical data, the results
of this article indicate that hormonal intervention in the injured
patient may now hold future therapeutic promise.
Burns
Two papers last year in Critical Care focused on burn care.
Acute renal failure is a relatively uncommon occurrence in
burn patients, but it carries a high mortality [30]. It also has
been a difficult area to study, due to the variability in
nomenclature and definitions used to describe kidney injury in
the existing literature. In addition, many of the previous studies
have been retrospective, using inconsistent data collection
methods and reproducible definitions for variables, outcome
measures, and reporting templates. In a 2008 Critical Care
article, Steinvall and colleagues [31] used a classification
system developed by the Acute Dialysis Quality Initiative
Group to prospectively describe the incidence and mortality of
acute renal injury. Their study involved a cohort of patients with
at least 20% total body surface area burns who were admitted
to a national burn center. Using the consensus-based
approach and its prospective definitions, the authors found
that 24% of their cohort developed some significant degree of
acute kidney injury, with 5% developing a reproducible
criterion for acute renal failure. Overall mortality for patients
with the proscribed degree of kidney injury was 14% and, as
expected, increased with severity of kidney injury: up to 83%
in patients with kidney failure as defined by the classification
system. This article adds to the knowledge base of the
incidence and associated factors related to kidney disease in
burn patients and also provides guidance for future studies.As in the case of renal failure, inhalational injury is a harbinger
of increased mortality in burn patients [32]. Despite the
development of a number of potential scoring systems aimed
at quantifying the potentiating effect of inhalation injury and
dermal injury, none of those approaches has been altogether
successful in terms of accurately predicting mortality [33].
However, Finnerty and colleagues [34] have shown that
children with burn injury have a marked alteration in inflam-
matory cytokines when compared with healthy children.
Therefore, in a follow-up study published last year in Critical
Care, the same group, Gauglitz and colleagues [35], showed
that patients with elevated interleukin-6 (IL-6) and IL-10 and
decreased IL-7 serum levels upon admission had a signifi-
cantly greater risk for mortality. This finding provides one
potential tool for critical care providers to better predict those
burn patients who would be at greater risk for mortality earlier
in the course of care.
Diagnostic issues
A basic tenet of current trauma care practice is that the
cervical spine remains vulnerable to further injury in patients
who have received significant blunt force trauma to neck and
who may have underlying unstable cervical spine injuries. In
an analysis of over 34,000 patients with major trauma,
Goldberg and colleagues [36] identified cervical spine
injuries in 2.4% of cases. Approximately 70% of those
cervical spine injuries were clinically significant insults [36].
This rate of cervical spine injury may be as high as 34% in the
subpopulation of patients with severe blunt trauma who
require ICU admission [37]. Although there are good data
and resulting established criteria for ruling out a significant
cervical spine injury in patients with normal mentation [38],
there is still some debate with regard to the removal of
cervical spine immobilization in those who remain comatose.
Many sources recommend a CT scan of the cervical spine
[39], but others have recommended that, in patients with a
CT that indicates no cervical injury, an MRI may be necessary
to detect injuries that may be missed by standard CT [40,41].
At the same time, others question some of the risks
associated with getting an MRI or whether prolonged cervical
immobilization outweighs the risks of missed injury. In another
2008 Critical Care trauma paper, Dunham and colleagues
[42] conducted a review to begin the process of answering
these questions. The researchers concluded that the risks of
secondary brain injury from cervical immobilization or an MRI
(largely due to consequences of protracted supine
positioning) are much greater than the risk of cervical spine
instability [42]. They specifically found that the risk for spinal
instability in comatose or obtunded patients with
unremarkable bony imaging was 2.5%. This was compared
with a 26% increased rate of ICU complications with
prolonged cervical collar use and a 27.8% incidence of
increasing ICP from less than 15 mm Hg to greater than
20 mm Hg. This complication presumably occurs by virtue of
the supine patient positioning (versus some degree of head
elevation) that is used to maintain cervical spine precautions.
In addition, neurosurgical ICU patients transported to
radiology had a greater number of secondary brain injury
events compared with those undergoing studies within the
unit. The MRI patients, for example, had significant ICP
increases during out-of-ICU transportation. With regard to
leaving the protective confines of the surgical ICU, 51% of
brain-injured patients transported out of the unit developed
complications such as hypoxia, hypotension, and increased
ICP. With respect to the positioning required for MRI,
Dunham and colleagues [42] noted not only that the flat
position likely increases ICP but also that the head ‘down’
position significantly increases the risks of aspiration and
ventilator-associated pneumonia. They suggest that, in some
comatose or obtunded patients with a negative CT scan and
no apparent spinal deficit, early collar removal is a safe and
reasonable strategy.
Early post-traumatic mortality is determined by the initial
traumatic impact and early resuscitation, whereas late
mortality is usually associated with the development of septic
inflammatory response syndrome and progresses to multiple
organ dysfunction syndrome and death. This pathophysio-
logical pathway is thought to be responsible for up to 80% of
trauma deaths in the ICU [43]. Cardiac function has been
described as having particular relevance to multiple organ
failure, but the traditional methods of assessment, such as
pulmonary artery catheterization or echocardiography, either
are invasive or may not be readily available in an ICU.
Therefore, Kirchhoff and colleagues [44] performed a cohort
study in which they compared serum NT-proBNP levels in
patients with minor signs of organ dysfunction, specifically
those with a Marshall Multiple Organ Dysfunction Score
(MODS) of 4 or less, with those with major signs of organ
dysfunction, namely a MODS of greater than 4. The
researchers found that, at admission, both groups had slightly
elevated NT-proBNP but that, at 24, 48, and 72 hours after
admission, the patients with the higher MODS had
significantly higher levels than those with the lower MODS.
They also showed that NT-proBNP levels correlated with
decreased cardiac index, thus suggesting that NT-proBNP
measurement may serve as a useful marker for post-traumatic
cardiac impairment.
Post-traumatic immunocompromise
Hemorrhagic shock states are known to produce a variety of
immunosuppressive effects that can lead to increased
susceptibility to infections and post-traumatic complications
like multiple organ dysfunction syndrome, multiple organ
failure, or adult respiratory distress syndrome [45-48]. While
the exact mechanisms of post-traumatic immunocompromise
still are not well understood, several studies have suggested
that functional and immunological alterations in the spleen
may play a major role [49-51]. In an experimental design
developed by Hostmann and colleagues [52], a murine model
of resuscitated hemorrhagic shock was used to detect
apoptosis in the spleen as a marker of cellular injury and
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lymphocytopenia immediately after severe hemorrhage that
did return to baseline within the subsequent 72 hours. They
also showed a rapid activation of splenic apoptosis in a
biphasic onset, both immediately after the hemorrhage and
72 hours after the bleeding was induced. This article thus
demonstrated two of the potential mechanisms for post-
traumatic immunosuppression and provides us with important
hypothesis-generating clues for future interventions.
Conclusions
The 2008 volume of Critical Care contained several articles
related to the care of injured patients. Proper care of patients
with TBI is necessary to prevent secondary brain injury. New
therapeutic interventions may be on the horizon. Consistent
approaches to the identification of renal injury and inhalational
trauma in patients with thermal injury may improve future
research and care. Reports from that volume also suggest
that the CT scan is an adequate method of identifying un-
stable cervical spine injuries in comatose or obtunded trauma
patients and that prolonged immobilization or MRI studies
may actually cause adverse outcomes. It was also shown that
NT-proBNP may be helpful in identifying post-traumatic
cardiac impairment and that the response of the splenic and
lymphocytic systems to massive hemorrhage may provide
clues to the pathophysiology (and future interventions) in
post-traumatic immunocompromise.
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